SUCROSE ESTERS OF FATTY ACIDS AND MONOGLYCERIDES Explanation These substances have been evaluated for acceptable daily intake for man (ADI) by the Joint FAO/WHO Expert Committee on Food Additives in 1969, 1973 and 1976 (see Annex I, Refs. 19, 32 and 40). Toxicological monographs were issued in 1969, 1973 and 1976 (see Annex I, Refs. 20, 33 and 41). Since the previous evaluation, additional data have become available and are summarized and discussed in the following monograph addendum. BIOLOGICAL DATA SUCROSE MONOSTEARATE BIOCHEMICAL ASPECTS Sucrose-monostearate was hydrolysed by mucosal homogenates of the rat small intestine (about 10% in 10 minutes), and by homogenates of rat liver (about 40% in 4 hours). Blood esterases were inactive (Shigeoka, et al., 1979). In vitro techniques, utilizing the everted sac of the rat intestine showed that the greater part of the U-14C sucrose monostearate was transferred to the serosal side, but most of the transferred activity was due to sucrose produced by hydrolyse. Little of the unchanged sucrose monostearate is transferred to the serosal side but appears to be accumulated in the tissue (Shigeoka, et al., 1979). Intestinal absorption of the esters through the mainline lymphatic system was studied in rats, administered either U-14C sucrose (*SMS) I-14C monostearate (SM*S) or U-14C sucrose (14C-SE) orally. 24 hours after administration of the test substance, 14C was measured in the lymph. About 20% 14C from SM*S was received in the lymph, whereas in the case of *SMS and 14C-SE, less than 2% of the 14C was received in the lymph (Shigeoka et al., 1979). SUCROSE MONOPALMITATE BIOCHEMICAL ASPECTS Sucrose monopalmitate is hydrolysed by artificial pancreatic juice in the presence of taurocholate, mucosal homogenates of the rat small intestine (about 30% in 10 minutes), and by homogenates of rat liver (about 40% in 4 hours). Some hydrolysis occurs in the presence of blood esterase: however, the rate is extremely slow compared to the other enzyme systems (Shigeoka et al., 1979). In everted rat intestine preparations, sucrose-1-14C-palmitate was incubated for one hour and the radioactivity measured in mucosal and serosal fluids and in whole tissue. At the end of incubation, the radioactivity of the mucosal ester had decreased by about 50%, while only about 1% of the unchanged ester had transferred to the serosal side (Shigeoka et al., 1979). The amount of the ester transferred to the lymph after oral administration was about 36% of the administered dose, suggesting that some ester had transferred to the lymph without being hydrolysed. No unchanged ester was found in portal and femoral blood (Shigeoka et al., 1979). Rats were dosed orally with sucrose 1-14C monopalmitate (SM*P), 1-14C Palmitic Acid (*PA), 250 mg/kg bw. 120 hours after administration of the test substance, the secretion of 14C from the SM*P dosed rats in urine, faeces and expired air (CO2) was 36%, 34% and 37%, and from the *PA dosed rats, 2.5%, 16% and 50% respectively. Most of the excretion occurred in the first 24 hours of the test. 14C label in the fatty tissue was 30-70 times that in blood. It was estimated that 15-20% of the 14C administered accumulated in fatty tissues (Shigeoka et al., 1979). SUCROSE MONO-OLEATE BIOCHEMICAL ASPECTS The gastrointestinal absorption of sucrose mono-oleate was determined in young adult male rats fed various mixtures of the triolein: sucrose mono-oleate. The animals were distributed into groups of 10 according to body weight. After one week's adaptation to the diet, the food consumption was recorded and the faeces were collected for each animal during the succeeding 10 days. Fatty acid analysis was performed on the feed and faeces, and this was used to determine the coefficient of absorbability for sucrose mono-oleate. It was found to be almost completely absorbed (Mattson, 1972). LARD AND TALLOW SUCROSE ESTERS BIOCHEMICAL ASPECTS Adult male rats of the Charles River CD strain were given, either by oral intubation or by i.p. injection, a solution of [14C] sucrose tallowate in propylene glycol in a single dose of 5, 50 or 100 mg/kg of bw. On the average, 5% of the oral dose of [14C] sucrose tallowate appeared in the urine and 11% in the faeces within 96 hours. 61.5% of the [14C] was recovered in the expired air. The administration of [14C] sucrose in similar experiments resulted in radioactive recoveries which approximated those found in the studies of sucrose tallowate. In the single i.p. injection studies of [14C] sucrose tallowate 61% and 19% of the activity was recovered in the urine and in expired air, respectively, within 19 hours, while negligible amounts appeared in the faeces (Daniel et al., 1979). In another study, a group of nine adult male rats [14C] sucrose tallowate was administered via intubation daily at a dose of 100 mg/kg of body weight for 21 days. Groups of three animals were killed on days 7, 14 and 21, and hepatic and adipose tissue were removed and analysed for radioactivity. There was no evidence of progressive accumulation of sucrose tallowate in either the live or adipose tissues. The results were comparable to those in which sucrose [14C] was administered to rats for seven days (Daniel et al., 1979). OBSERVATIONS IN MAN Three human volunteers were given 1 g of sucrose tallowate in a mixture of butter and cream cheese, and 24-hour urines were collected and analysed for sucrose. In addition, each volunteer was given a solution of 10 g of sucrose in 100 ml of water and urine collections and analysis were performed as stated above. Urinary analysis for sucrose showed the presence of 6, 12 and 13 ppm of sucrose in the dietary study and 7, 15 and 24 ppm of sucrose in the liquid study. These data suggest that the sucrose tallow esters were rapidly hydrolysed in and almost completely absorbed from the gastrointestinal tract and that very little accumulated in the hepatic and adipose tissues when the esters were administered orally to rats. Since minute amounts of sucrose appeared in the human urinalysis studies, this too suggested that, like the rat, the esters were rapidly hydrolysed and absorbed in the human volunteers (Daniel et al., 1979). TOXICOLOGICAL STUDIES Short-term studies Dog Sucrose esters from beef tallow were provided in the diet to groups of four male and four female pure bred beagle dogs at concentrations of 3000, 10 000 or 30 000 ppm for 26 weeks. An additional group received an identical diet with the exception of the sucrose ester and acted as the control. Body weight changes, food intake and water consumption were not affected by the administration of the ester. The animals in the two highest dosage groups exhibited periods of soft faeces during the study. The ophthalmic and haematologic examinations, the urinalysis, the organ weights and macroscopic examinations revealed no adverse effects which could be attributed to the intake of the sucrose esters. The blood chemistry studies showed that the majority of the parameters measured in the treated animals were within acceptable limits. However, there was a compound-related increase in plasma alanine amino-transferase in some of the treated animals. The histopathological examinations were unremarkable, except that the kidneys of all the female dogs contained moderate amounts of fat. However, this effect was not related to the amount of sucrose ester in the diet (Virgo, 1979). Long-term studies Rat Groups each of 30 SC-JCL homogenous, four-week-old rats, evenly divided by sex, were maintained at a diet containing 0.0, 0.3, 1.0 or 3% sucrose ester of tallow for 18 months. Body weight changes, survival, food and compound consumption and food efficiency were monitored through the experiment. No compound-related effects were reported. Some changes were noticed in the haematological parameters, serum biochemistries, organ weights, and urinalysis. However, none of these effects could be attributed to the administration of the sucrose ester. Histopathological evaluations were performed on all surviving animals at the end of the study, and no compound-related, toxic and/or carcinogenic lesion were found (Kotani, 1974). MIXED PALMITIC AND STEARIC ACID ESTERS OF SUCROSE TOXICOLOGICAL STUDIES Short-term studies Groups of three male and female beagle dogs received in their diet sucrose esters of mixed stearic and palmitic acids at concentrations of 0.3%, 1% or 3.0% daily for 26 weeks. A separate group of three male and female dogs maintained on diet alone served as control. During the entire study, the group mean daily intake of the esters was 102, 345 and 1091 mg/kg in male dogs, and 104, 367 and 1139 mg/kg in female dogs in the three corresponding treatment groups. No animal died during the study. The plasma glucose levels at 13 weeks were significantly elevated. However, this effect was dependent neither on the dose, nor on the length of the study, and thus, could not be attributed to the administration of the ester. The body weights, food/water consumption, clinical chemistry, haematology, and urinalysis were essentially within normal ranges. Gross and microscopical examinations of tissues and major organs revealed no significant changes that could be attributed to the ingestion of the esters (Chesterman et al., 1979). Comments Metabolic studies have been reported in a number of sucrose esters, namely sucrose monostearate, sucrose monopalmitate, sucrose mono-oleate and lard and tallow sucrose esters. In the rat, it is apparent that the sucrose esters are hydrolysed in the mucosal epithelium cells before intestinal absorption. This observation is also supported by the in vitro studies in which rapid hydrolysis of the esters occurs in the presence of mucosal homogenates of the intestine, and only slow hydrolysis in the presence of liver preparations, and negligible hydrolysis by pancreatic juice in the presence of taurocholate. Studies with humans fed sucrose tallowates, also indicate that they are absorbed from the GI tract. There is no evidence of progressive accumulation of the esters or metabolites, in either experimental animals or man. A short-term feeding study in the dog (26 weeks), with either sucrose esters of beef tallow, or sucrose esters of mixed stearic and palmitic acids, showed no adverse effects related to administration of the test compound. The no-effect level was established in the rat at 500 mg/kg bw and because these substances are hydrolysed in the gut to normal food constituents, a lower safety factor was used to calculate the ADI. EVALUATION Level causing no toxicological effect Rat: 10 000 ppm (1%) in the diet equivalent to 500 mg/kg bw. Estimate of acceptable daily intake for man 0-10 mg/kg bw. REFERENCES Chesterman, H., Heywood, R., Allen, T. R., Street, A. E., Read R. & Gapinath, C. Sucrose ester of mixed stearic and palmitic acid dietary study in beagle dogs. Unpublished report from Huntingdon Research Centre, submitted by Ryoto Company Limited, Tokyo, Japan, 1979 Daniel, J. W., Marshall, C. J., Jones, H. F. & Snodin, D. J. The metabolism of beef tallow sucrose esters in rat and man. Fd. Cosmet. Toxicol., 17, 19-21, 1979 Kotani, S., Imahori, A., Tiba, S. & Shiobara, S. Chronic toxicological evaluation of DK-Ester-F-110 (sucrose fatty acid ester). Unpublished report from Juntendo University - Public Hygiene Laboratory, submitted by Dai-Ichi Kogyo Seiyaku Co., Kyoto, Japan, 1974 Mattson, F. & Nolen, G. Absorbability by rats of compounds containing from one to eight ester groups. J. Nutr., 102, 1171-1175, 1972 Shigeoka, T., Katsuki, M., Izawa, O. & Kitazawa, K. Metabolic study on sucrose esters of stearic and palmitic acid in rats. Unpublished report by Mitsubishi-Kosei Institute of Toxicological and Environmental Sciences, Tokyo, Japan, 1979 Virgo, D. M., Ashby, R., Cummins, H. A., Hepworth, P. L. & Finn, J. P. Sucrose esters from beef tallow: toxicity in dietary administration to beagle dogs for 26 weeks. Unpublished report by Life Science Research, submitted by Tate & Lyle Limited, Reading, Berkshire, England, 1979
See Also: Toxicological Abbreviations Sucrose esters of fatty acids and sucroglycerides (WHO Food Additives Series 10) Sucrose esters of fatty acids and sucroglycerides (WHO Food Additives Series 35) Sucrose esters of fatty acids and sucroglycerides (WHO Food Additives Series 40)